A modern tactical gacha game may have flown under the radar for some, but it really shouldn't, as it's a powerful blend of ...

In the study, no matter how much weight participants lost, regain was four times faster for people ending medication use than ...

ElevateBio, LLC (ElevateBio), a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced its sixth consecutive year of revenue growth, driven ...

Picture yourself in retirement. Maybe you're thinking about beach vacations, Sunday morning coffee on the porch, and finally ...

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...

Pupil dilation provides a physiological readout of information gain during the brain's internal process of belief updating in the context of associative learning.

A new study shows that people don’t just regain weight after stopping GLP-1 drugs, they see other positive health markers reverse – leading to questions about long-term impacts and solutions ...

Metropolitan Bank & Trust Co. sees a more constructive economic backdrop emerging this year as both global and local conditions gradually normalize, following a volatile 2025 marked by global policy ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the ...

Key Takeaways If the new year has you seeking a fresh outlook on life, investing in your self-care and beauty routine may be ...

Euro-area inflation hitting 2% may seem like success, but it masks a fragile equilibrium with risks on both sides of the goal, highlighting the need for policies that can absorb shocks and ...

Addex spin-out Neurosterix begins phase 1 study with M4 PAM - NTX-253 for schizophrenia: Geneva, Switzerland Thursday, January 8, 2026, 12:00 Hrs [IST] Addex Therapeutics, a clini ...